Design Cloud

Image Name

News

Home page

Party group dynamics

Employee activity

Wanbangde Pharmaceutical Group Co., Ltd. Announces Environmental Measures for New Technical Upgrade Project: Annual Production Capacity of 5 tons of Resorcinol API and 500 tons of Cimetidine API

Date:

11 Jun,2022

The company plans to build a technical upgrade project aimed at producing 5 tons of resorcinol API and 500 tons of cimetidine API annually. The construction details of this project are now being publicly announced.

Previous page

Adhering to the Work Safety Law and Taking on Primary Responsibility | Wanbangde Pharmaceutical Group Holds 2022 "Work Safety Month" Kickoff Meeting

Spring Outing Diary | Wanbangde Pharmaceutical Group’s National Fitness Event Successfully Concludes

Next page

Related Recommendations

Image Name

2024/12/30

News | The Annual Meeting of Wanbande Pharmaceutical Group's Academician and Expert Workstation Successfully Held

Image Name

2024/12/30

For three consecutive years, Wanbande Pharmaceutical Group has been recognized among the Top 500 High-Tech Enterprises in Zhejiang Province for Innovation Capability!

Image Name

2024/12/30

Wanbangde achieves another breakthrough in innovative drug development—WP103 holds the potential to address the critical clinical need for treating neonatal HIE! This globally rare FDA dual-designated drug has once again received IND application acceptance.

< 1...3 4 5...78 > proceed page

Image Name

Website Development: China Enterprise Dynamics Taizhou

Business license

浙ICP备10002622号-38